289 related articles for article (PubMed ID: 25882749)
1. 6R-tetrahydrobiopterin treated PKU patients below 4 years of age: Physical outcomes, nutrition and genotype.
Aldámiz-Echevarría L; Bueno MA; Couce ML; Lage S; Dalmau J; Vitoria I; Llarena M; Andrade F; Blasco J; Alcalde C; Gil D; García MC; González-Lamuño D; Ruiz M; Ruiz MA; Peña-Quintana L; González D; Sánchez-Valverde F
Mol Genet Metab; 2015 May; 115(1):10-6. PubMed ID: 25882749
[TBL] [Abstract][Full Text] [Related]
2. Tetrahydrobiopterin therapy vs phenylalanine-restricted diet: impact on growth in PKU.
Aldámiz-Echevarría L; Bueno MA; Couce ML; Lage S; Dalmau J; Vitoria I; Andrade F; Llarena M; Blasco J; Alcalde C; Gil D; García MC; González-Lamuño D; Ruiz M; Ruiz MA; González D; Sánchez-Valverde F
Mol Genet Metab; 2013 Aug; 109(4):331-8. PubMed ID: 23810227
[TBL] [Abstract][Full Text] [Related]
3. Anthropometric characteristics and nutrition in a cohort of PAH-deficient patients.
Aldámiz-Echevarría L; Bueno MA; Couce ML; Lage S; Dalmau J; Vitoria I; Andrade F; Blasco J; Alcalde C; Gil D; García MC; González-Lamuño D; Ruiz M; Peña-Quintana L; Ruiz MA; González D; Sánchez-Valverde F
Clin Nutr; 2014 Aug; 33(4):702-17. PubMed ID: 24120886
[TBL] [Abstract][Full Text] [Related]
4. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
Trefz FK; Blau N
Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
[TBL] [Abstract][Full Text] [Related]
5. Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapy.
Lambruschini N; Pérez-Dueñas B; Vilaseca MA; Mas A; Artuch R; Gassió R; Gómez L; Gutiérrez A; Campistol J
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S54-60. PubMed ID: 16040265
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.
Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N
Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520
[TBL] [Abstract][Full Text] [Related]
7. The relationship between dietary intake, growth and body composition in Phenylketonuria.
Evans M; Truby H; Boneh A
Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202
[TBL] [Abstract][Full Text] [Related]
8. A limited spectrum of phenylalanine hydroxylase mutations is observed in phenylketonuria patients in western Poland and implications for treatment with 6R tetrahydrobiopterin.
Dobrowolski SF; Borski K; Ellingson CC; Koch R; Levy HL; Naylor EW
J Hum Genet; 2009 Jun; 54(6):335-9. PubMed ID: 19444284
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of patients with phenylketonuria treated with tetrahydrobiopterin: a seven years experience.
Scala I; Concolino D; Della Casa R; Nastasi A; Ungaro C; Paladino S; Capaldo B; Ruoppolo M; Daniele A; Bonapace G; Strisciuglio P; Parenti G; Andria G
Orphanet J Rare Dis; 2015 Feb; 10():14. PubMed ID: 25757997
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria.
Muntau AC; Röschinger W; Habich M; Demmelmair H; Hoffmann B; Sommerhoff CP; Roscher AA
N Engl J Med; 2002 Dec; 347(26):2122-32. PubMed ID: 12501224
[TBL] [Abstract][Full Text] [Related]
11. Incidence of BH4-responsiveness in phenylalanine-hydroxylase-deficient Italian patients.
Fiori L; Fiege B; Riva E; Giovannini M
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S67-74. PubMed ID: 16198137
[TBL] [Abstract][Full Text] [Related]
12. Unresponsiveness to tetrahydrobiopterin of phenylalanine hydroxylase deficiency.
Ponzone A; Porta F; Mussa A; Alluto A; Ferraris S; Spada M
Metabolism; 2010 May; 59(5):645-52. PubMed ID: 19913839
[TBL] [Abstract][Full Text] [Related]
13. Spanish BH4-responsive phenylalanine hydroxylase-deficient patients: evolution of seven patients on long-term treatment with tetrahydrobiopterin.
Bélanger-Quintana A; García MJ; Castro M; Desviat LR; Pérez B; Mejía B; Ugarte M; Martínez-Pardo M
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S61-6. PubMed ID: 16165389
[TBL] [Abstract][Full Text] [Related]
14. Response of patients with phenylketonuria in the US to tetrahydrobiopterin.
Matalon R; Michals-Matalon K; Koch R; Grady J; Tyring S; Stevens RC
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S17-21. PubMed ID: 16143554
[TBL] [Abstract][Full Text] [Related]
15. Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria.
Fiege B; Blau N
J Pediatr; 2007 Jun; 150(6):627-30. PubMed ID: 17517248
[TBL] [Abstract][Full Text] [Related]
16. The tetrahydrobiopterin loading test in 36 patients with hyperphenylalaninaemia: evaluation of response and subsequent treatment.
Bóveda MD; Couce ML; Castiñeiras DE; Cocho JA; Pérez B; Ugarte M; Fraga JM
J Inherit Metab Dis; 2007 Oct; 30(5):812. PubMed ID: 17603758
[TBL] [Abstract][Full Text] [Related]
17. Tetrahydrobiopterin-responsive phenylketonuria: the New South Wales experience.
Mitchell JJ; Wilcken B; Alexander I; Ellaway C; O'Grady H; Wiley V; Earl J; Christodoulou J
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S81-5. PubMed ID: 16091307
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria.
Heintz C; Cotton RG; Blau N
Hum Mutat; 2013 Jul; 34(7):927-36. PubMed ID: 23559577
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment of patients with mild and classical phenylketonuria by tetrahydrobiopterin.
Trefz FK; Scheible D; Frauendienst-Egger G; Korall H; Blau N
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S75-80. PubMed ID: 16242984
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study.
Demirdas S; Maurice-Stam H; Boelen CC; Hofstede FC; Janssen MC; Langendonk JG; Mulder MF; Rubio-Gozalbo ME; van Spronsen FJ; de Vries M; Grootenhuis MA; Bosch AM
Mol Genet Metab; 2013; 110 Suppl():S49-56. PubMed ID: 24100246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
